About: Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.69 (-2.18%)
CMMBNASDAQChemomab Therapeutics Ltd DRC
Chemomab Therapeutics Ltd DRC share price
CMMB price activity
Last Price
$2.690
Change (24hr)
-0.06 USD (-2.18%)
Volume
76.58K
Volume (4w avg)
-
Open
$2.75
Day Range
$2.60 - $2.80
Previous Close
$2.75
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
CMMB price performance
Delayed
09 Sep, 8:00 pm GMT+0
CMMB Market Signals